| Secukinumab, an interleukin-17A inhibitor, in ankylosing spondylitis D Baeten, J Sieper, J Braun, X Baraliakos, M Dougados, P Emery, ... New England journal of medicine 373 (26), 2534-2548, 2015 | 1112 | 2015 |
| Spondyloarthritis M Dougados, D Baeten The Lancet 377 (9783), 2127-2137, 2011 | 997 | 2011 |
| Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial D Baeten, X Baraliakos, J Braun, J Sieper, P Emery, D Van der Heijde, ... The Lancet 382 (9906), 1705-1713, 2013 | 730 | 2013 |
| Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis JJ Haringman, DM Gerlag, AH Zwinderman, TJM Smeets, MC Kraan, ... Annals of the rheumatic diseases 64 (6), 834-838, 2005 | 528 | 2005 |
| Systematic validation of specific phenotypic markers for in vitro polarized human macrophages CA Ambarus, S Krausz, M van Eijk, J Hamann, T Radstake, KA Reedquist, ... Journal of immunological methods 375 (1-2), 196-206, 2012 | 494 | 2012 |
| Randomized double‐blind comparison of chimeric monoclonal antibody to tumor necrosis factor α (infliximab) versus placebo in active spondylarthropathy F Van Den Bosch, E Kruithof, D Baeten, A Herssens, F De Keyser, ... Arthritis & Rheumatism 46 (3), 755-765, 2002 | 493 | 2002 |
| Myelin oligodendrocyte glycoprotein–specific T and B cells cooperate to induce a Devic-like disease in mice E Bettelli, D Baeten, A Jäger, RA Sobel, VK Kuchroo The Journal of clinical investigation 116 (9), 2393-2402, 2006 | 411 | 2006 |
| Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor α (infliximab) in spondyloarthropathy: an open pilot study F Van den Bosch, E Kruithof, D Baeten, F De Keyser, H Mielants, EM Veys Annals of the Rheumatic Diseases 59 (6), 428-433, 2000 | 403 | 2000 |
| Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance S Brouard, E Mansfield, C Braud, L Li, M Giral, S Hsieh, D Baeten, ... Proceedings of the National Academy of Sciences 104 (39), 15448-15453, 2007 | 401 | 2007 |
| Synovial histopathology of psoriatic arthritis, both oligo-and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis E Kruithof, D Baeten, L De Rycke, B Vandooren, D Foell, J Roth, ... Arthritis research & therapy 7, 1-12, 2005 | 345 | 2005 |
| Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study D Baeten, M Østergaard, JCC Wei, J Sieper, P Järvinen, LS Tam, ... Annals of the rheumatic diseases 77 (9), 1295-1302, 2018 | 344 | 2018 |
| Ankylosing spondylitis and bowel disease M Rudwaleit, D Baeten Best practice & research Clinical rheumatology 20 (3), 451-471, 2006 | 324 | 2006 |
| Prevalence of peripheral and extra-articular disease in ankylosing spondylitis versus non-radiographic axial spondyloarthritis: a meta-analysis JJ de Winter, LJ van Mens, D van der Heijde, R Landewé, DL Baeten Arthritis research & therapy 18, 1-11, 2016 | 318 | 2016 |
| Interleukin‐17–positive mast cells contribute to synovial inflammation in spondylarthritis T Noordenbos, N Yeremenko, I Gofita, M van de Sande, PP Tak, ... Arthritis & Rheumatism 64 (1), 99-109, 2012 | 313 | 2012 |
| A randomized controlled trial with an anti‐CCL2 (anti–monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis JJ Haringman, DM Gerlag, TJM Smeets, D Baeten, F Van den Bosch, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2006 | 293 | 2006 |
| Effect of secukinumab on clinical and radiographic outcomes in ankylosing spondylitis: 2-year results from the randomised phase III MEASURE 1 study J Braun, X Baraliakos, A Deodhar, D Baeten, J Sieper, P Emery, A Readie, ... Annals of the rheumatic diseases 76 (6), 1070-1077, 2017 | 283 | 2017 |
| Immunomodulatory effects of anti–tumor necrosis factor α therapy on synovium in spondylarthropathy: histologic findings in eight patients from an open‐label pilot study D Baeten, E Kruithof, F Van den Bosch, P Demetter, N Van Damme, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2001 | 274 | 2001 |
| Specific presence of intracellular citrullinated proteins in rheumatoid arthritis synovium: relevance to antifilaggrin autoantibodies D Baeten, I Peene, A Union, L Meheus, M Sebbag, G Serre, EM Veys, ... Arthritis & Rheumatism 44 (10), 2255-2262, 2001 | 258 | 2001 |
| Ankylosing spondylitis SM Van Der Linden, D Baeten, WP Maksymowych Kelley's Textbook of Rheumatology: Volume 1-2, Ninth Edition, 1202-1220. e5, 2012 | 250 | 2012 |
| Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL … S Glatt, D Baeten, T Baker, M Griffiths, L Ionescu, ADG Lawson, A Maroof, ... Annals of the rheumatic diseases 77 (4), 523-532, 2018 | 244 | 2018 |
